EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Proteomics and Recurrence of Atrial Fibrillation: A Pilot Study Nested in the PREDIMAR Trial

Cristina Razquin, Joaquín Fernandez-Irigoyen, María Teresa Barrio-López, Begoña López, Susana Ravassa, Pablo Ramos, Rosa Macías-Ruíz, Alicia Ibañez Criado, Enrique Santamaría, Leticia Goni, Eduardo Castellanos, Jose Luis Ibañez Criado und 5 weitere

Lifestyle Genomics · 2025

DOI: 10.1159/000543639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lifestyle Genomics, 2025. Verfasst von Cristina Razquin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine and Public Health, IDISNA (Instituto de Investigación Sanitaria de Navarra), University of Navarra, Pamplona, Spain…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Proteomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide. Although catheter ablation is the most efficacious therapy, relapses occur frequently (30%) in the first year after ablation. Novel biomarkers of recurrence are needed for a better prediction of recurrence and management of AF. In this pilot study, we aimed to analyze the baseline proteome of subjects included in a case-control study to find differential proteins associated with AF recurrence.

Methods

Baseline serum proteomics (354 proteins) data from 16 cases (recurrent AF) and 17 controls (non-recurrent) were obtained using MS/MS analysis. A false discovery rate was performed using a nonlinear fitting method for the selection of proteins. Logistic regression models were used to further analyze the association between differentially expressed proteins and AF recurrence.

Results

Ten proteins were differentially represented in cases vs. controls. Two were upregulated in the cases compared to the controls: keratin type I cytoskeletal 17 (Fold-change [FC] = 2.14; p = 0.017) and endoplasmic bifunctional protein (FC = 1.65; p = 0.032). Eight were downregulated in the cases compared to the controls: C4bpA (FC = 0.64; p = 0.006), coagulation factor XI (FC = 0.83; p = 0.011), CLIC1 (FC = 0.62; p = 0.017), haptoglobin (FC = 0.37; p = 0.021), Ig alpha-2 chain C region (FC = 0.49; p = 0.022), C4bpB (FC = 0.73; p = 0.028), N-acetylglucosamine-1-phosphotransferase subunit gamma (FC = 0.61; p = 0.033), and platelet glycoprotein Ib alpha chain (FC = 0.84; p = 0.038).

Conclusion

This pilot study identifies ten differentially expressed serum proteins associated with AF recurrence, offering potential biomarkers for improved prediction and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationProteomicsHumansPilot ProjectsMaleFemaleCase-Control StudiesRecurrenceMiddle AgedBiomarkersAgedTandem Mass SpectrometryCatheter AblationProteomeBlood Proteins

Stichwörter der Autor:innen

Atrial fibrillationPREDIMARProteomicsRecurrence

Substanzen

BiomarkersProteomeBlood Proteins

Autor:innen und Institutionen

  • Department of Preventive Medicine and Public Health, IDISNA (Instituto de Investigación Sanitaria de Navarra), University of Navarra, Pamplona, Spain, crazquin@unav.es.
  • CIBER Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III, Madrid, Spain, crazquin@unav.es.
  • Proteomics Platform, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
  • Electrophysiology Laboratory and Arrhythmia Unit, HM CIEC MADRID (Centro Integral de Enfermedades Cardiovasculares), Hospital Universitario HM Montepríncipe, HM Hospitales, Madrid, Spain.
  • Instituto de Investigación Sanitaria HM Hospitales, Madrid, Spain.
  • Program of Cardiovascular Disease, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain.

Zitieren

APA

Razquin, C., Fernandez-Irigoyen, J., Barrio-López, M. T., López, B., Ravassa, S., Ramos, P., Macías-Ruíz, R., Ibañez Criado, A., Santamaría, E., Goni, L., Castellanos, E., Ibañez Criado, J. L., Tercedor, L., García-Bolao, I., Martínez-González, M. A., Almendral, J., & Ruiz-Canela, M. (2025). Proteomics and Recurrence of Atrial Fibrillation: A Pilot Study Nested in the PREDIMAR Trial. Lifestyle Genomics. https://doi.org/10.1159/000543639

Vancouver

Razquin C, Fernandez-Irigoyen J, Barrio-López MT, López B, Ravassa S, Ramos P, et al. Proteomics and Recurrence of Atrial Fibrillation: A Pilot Study Nested in the PREDIMAR Trial. Lifestyle Genomics. 2025. doi:10.1159/000543639

BibTeX
@article{Razquin2025,
  author = {Razquin, Cristina and Fernandez-Irigoyen, Joaquín and Barrio-López, María Teresa and López, Begoña and Ravassa, Susana and Ramos, Pablo and Macías-Ruíz, Rosa and Ibañez Criado, Alicia and Santamaría, Enrique and Goni, Leticia and Castellanos, Eduardo and Ibañez Criado, Jose Luis and Tercedor, Luis and García-Bolao, Ignacio and Martínez-González, Miguel A and Almendral, Jesús and Ruiz-Canela, Miguel},
  title = {Proteomics and Recurrence of Atrial Fibrillation: A Pilot Study Nested in the PREDIMAR Trial},
  journal = {Lifestyle Genomics},
  year = {2025},
  doi = {10.1159/000543639}
}
Kostenlos starten →